<b>Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G</b> Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.2337/figshare.28485281.v1
Revascularization strategies failed to improve outcome in diabetic (DM) patients with peripheral artery disease (PAD). Histone modifications are key modulators of gene expression and could play a role in angiogenic response. This study investigates the role of chromatin remodelling in modulating angiogenesis in DM. RNA sequencing (RNA-seq) and angiogenic assays (cell migration and tube formation) were performed in human aortic endothelial cells (HAECs) exposed to normal glucose (NG, 5 mM) or high glucose (HG, 25 mM) for 48h. The expression of the histone methyltransferase SETD7 and its chromatin signature at histone 3 on lysine 4 (H3K4me1) were investigated by Western blot and chromatin immunoprecipitation (ChIP). Diabetic mice were treated with the SETD7 inhibitor (R)-PFI-2 or vehicle and underwent hindlimb ischemia by femoral artery ligation. The experimental findings were translated into two cohorts of DM patients with PAD. RNA-seq in HG-treated HAECs unveiled SETD7 as the top-ranking transcript. SETD7 upregulation was associated with increased H3K4me1 levels and defective angiogenesis. Both SETD7 depletion and (R)PFI-2 rescued hyperglycemia-induced impairment of HAECs migration and tube formation, while SETD7 overexpression blunted the angiogenic response. RNA-seq and ChIP assays showed that SETD7-induced H3K4me1 enables the transcription of the angiogenesis inhibitor semaphorin-3G (SEMA3G) by increasing chromatin accessibility to PPARγ. In diabetic mice with hindlimb ischemia, (R)-PFI-2 improved limb perfusion by suppressing SEMA3G. SETD7/SEMA3G axis was upregulated in DM patients with PAD. Of note, (R)-PFI-2 restored angiogenic properties in endothelial cells collected from DM patients. These findings show that SETD7 is a druggable epigenetic target in diabetic PAD.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.2337/figshare.28485281.v1
- OA Status
- green
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4408023583
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4408023583Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2337/figshare.28485281.v1Digital Object Identifier
- Title
-
<b>Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G</b>Work title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-27Full publication date if available
- Authors
-
S A Mohammed, Era Gorica, Mattia Albiero, Gergely Karsai, Alessandro Mengozzi, C. Caravaggi, Samuele Ambrosini, Stefano Masi, Maria Cristina Vinci, Omer Dzemali, Gaia Spinetti, Sanjay Rajagopalan, Assam El‐Osta, Jaroslav Pelisek, Frank Ruschitzka, Gian Paolo Fadini, Sarah Costantino, Francesco PaneniList of authors in order
- Landing page
-
https://doi.org/10.2337/figshare.28485281.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- Concepts
-
Psychological repression, Semaphorin, Cancer research, Cell biology, Medicine, Biology, Internal medicine, Genetics, Gene, Receptor, Gene expressionTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4408023583 |
|---|---|
| doi | https://doi.org/10.2337/figshare.28485281.v1 |
| ids.doi | https://doi.org/10.2337/figshare.28485281.v1 |
| ids.openalex | https://openalex.org/W4408023583 |
| fwci | |
| type | preprint |
| title | <b>Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G</b> |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12061 |
| topics[0].field.id | https://openalex.org/fields/28 |
| topics[0].field.display_name | Neuroscience |
| topics[0].score | 0.9926999807357788 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2804 |
| topics[0].subfield.display_name | Cellular and Molecular Neuroscience |
| topics[0].display_name | Axon Guidance and Neuronal Signaling |
| topics[1].id | https://openalex.org/T13505 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9380999803543091 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2736 |
| topics[1].subfield.display_name | Pharmacology |
| topics[1].display_name | Apelin-related biomedical research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C186310378 |
| concepts[0].level | 4 |
| concepts[0].score | 0.8784957528114319 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q941796 |
| concepts[0].display_name | Psychological repression |
| concepts[1].id | https://openalex.org/C132538176 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8491606712341309 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q24768287 |
| concepts[1].display_name | Semaphorin |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5436986088752747 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C95444343 |
| concepts[3].level | 1 |
| concepts[3].score | 0.3474363684654236 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[3].display_name | Cell biology |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.31104397773742676 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.28191447257995605 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.19779285788536072 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C54355233 |
| concepts[7].level | 1 |
| concepts[7].score | 0.18033689260482788 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[7].display_name | Genetics |
| concepts[8].id | https://openalex.org/C104317684 |
| concepts[8].level | 2 |
| concepts[8].score | 0.16009682416915894 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[8].display_name | Gene |
| concepts[9].id | https://openalex.org/C170493617 |
| concepts[9].level | 2 |
| concepts[9].score | 0.13840654492378235 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[9].display_name | Receptor |
| concepts[10].id | https://openalex.org/C150194340 |
| concepts[10].level | 3 |
| concepts[10].score | 0.0755515992641449 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[10].display_name | Gene expression |
| keywords[0].id | https://openalex.org/keywords/psychological-repression |
| keywords[0].score | 0.8784957528114319 |
| keywords[0].display_name | Psychological repression |
| keywords[1].id | https://openalex.org/keywords/semaphorin |
| keywords[1].score | 0.8491606712341309 |
| keywords[1].display_name | Semaphorin |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.5436986088752747 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/cell-biology |
| keywords[3].score | 0.3474363684654236 |
| keywords[3].display_name | Cell biology |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.31104397773742676 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.28191447257995605 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.19779285788536072 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/genetics |
| keywords[7].score | 0.18033689260482788 |
| keywords[7].display_name | Genetics |
| keywords[8].id | https://openalex.org/keywords/gene |
| keywords[8].score | 0.16009682416915894 |
| keywords[8].display_name | Gene |
| keywords[9].id | https://openalex.org/keywords/receptor |
| keywords[9].score | 0.13840654492378235 |
| keywords[9].display_name | Receptor |
| keywords[10].id | https://openalex.org/keywords/gene-expression |
| keywords[10].score | 0.0755515992641449 |
| keywords[10].display_name | Gene expression |
| language | en |
| locations[0].id | doi:10.2337/figshare.28485281.v1 |
| locations[0].is_oa | False |
| locations[0].source | |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.2337/figshare.28485281.v1 |
| locations[1].id | pmh:oai:figshare.com:article/28485281 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by-nc-sa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Figure |
| locations[1].license_id | https://openalex.org/licenses/cc-by-nc-sa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5101624632 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2365-5037 |
| authorships[0].author.display_name | S A Mohammed |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Shafeeq A. Mohammed |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5008791189 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-1743-2013 |
| authorships[1].author.display_name | Era Gorica |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Era Gorica |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5045364954 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4142-9738 |
| authorships[2].author.display_name | Mattia Albiero |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mattia Albiero |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5043834080 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6840-682X |
| authorships[3].author.display_name | Gergely Karsai |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Gergely Karsai |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5044406653 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2834-9725 |
| authorships[4].author.display_name | Alessandro Mengozzi |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Alessandro Mengozzi |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5063339321 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | C. Caravaggi |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Carlo Maria Caravaggi |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5024381247 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-2112-1122 |
| authorships[6].author.display_name | Samuele Ambrosini |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Samuele Ambrosini |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5017742947 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-7591-3686 |
| authorships[7].author.display_name | Stefano Masi |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Stefano Masi |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5043790154 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-6323-147X |
| authorships[8].author.display_name | Maria Cristina Vinci |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Maria Cristina Vinci |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5007318480 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-7910-5152 |
| authorships[9].author.display_name | Omer Dzemali |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Omer Dzemali |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5079026709 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-7996-6809 |
| authorships[10].author.display_name | Gaia Spinetti |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Gaia Spinetti |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5022334933 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-6669-8163 |
| authorships[11].author.display_name | Sanjay Rajagopalan |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Sanjay Rajagopalan |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5009458371 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-2969-9137 |
| authorships[12].author.display_name | Assam El‐Osta |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Assam El-Osta |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5020472674 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-8951-132X |
| authorships[13].author.display_name | Jaroslav Pelisek |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Jaroslav Pelisek |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5013727186 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-5972-0596 |
| authorships[14].author.display_name | Frank Ruschitzka |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Frank Ruschitzka |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5027393457 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-6510-2097 |
| authorships[15].author.display_name | Gian Paolo Fadini |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Gian Paolo Fadini |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5035872503 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-3003-7213 |
| authorships[16].author.display_name | Sarah Costantino |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Sarah Costantino |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5050799541 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-6483-7844 |
| authorships[17].author.display_name | Francesco Paneni |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | Francesco Paneni |
| authorships[17].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | <b>Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G</b> |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12061 |
| primary_topic.field.id | https://openalex.org/fields/28 |
| primary_topic.field.display_name | Neuroscience |
| primary_topic.score | 0.9926999807357788 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2804 |
| primary_topic.subfield.display_name | Cellular and Molecular Neuroscience |
| primary_topic.display_name | Axon Guidance and Neuronal Signaling |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | pmh:oai:figshare.com:article/28485281 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306400572 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| best_oa_location.source.host_organization | https://openalex.org/I196829312 |
| best_oa_location.source.host_organization_name | La Trobe University |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I196829312 |
| best_oa_location.license | cc-by-nc-sa |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Figure |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-sa |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | |
| primary_location.id | doi:10.2337/figshare.28485281.v1 |
| primary_location.is_oa | False |
| primary_location.source | |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.2337/figshare.28485281.v1 |
| publication_date | 2025-02-27 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.3 | 92 |
| abstract_inverted_index.4 | 95 |
| abstract_inverted_index.5 | 69 |
| abstract_inverted_index.a | 27, 244 |
| abstract_inverted_index.25 | 75 |
| abstract_inverted_index.DM | 134, 221, 236 |
| abstract_inverted_index.In | 203 |
| abstract_inverted_index.Of | 225 |
| abstract_inverted_index.as | 144 |
| abstract_inverted_index.at | 90 |
| abstract_inverted_index.by | 99, 121, 197, 213 |
| abstract_inverted_index.in | 7, 29, 40, 43, 58, 139, 220, 231, 248 |
| abstract_inverted_index.is | 243 |
| abstract_inverted_index.of | 21, 37, 81, 133, 167, 191 |
| abstract_inverted_index.on | 93 |
| abstract_inverted_index.or | 71, 115 |
| abstract_inverted_index.to | 4, 65, 201 |
| abstract_inverted_index.DM. | 44 |
| abstract_inverted_index.RNA | 45 |
| abstract_inverted_index.The | 79, 125 |
| abstract_inverted_index.and | 24, 48, 53, 86, 102, 117, 156, 162, 170, 181 |
| abstract_inverted_index.are | 18 |
| abstract_inverted_index.for | 77 |
| abstract_inverted_index.its | 87 |
| abstract_inverted_index.key | 19 |
| abstract_inverted_index.mM) | 70, 76 |
| abstract_inverted_index.the | 35, 82, 111, 145, 177, 189, 192 |
| abstract_inverted_index.two | 131 |
| abstract_inverted_index.was | 150, 218 |
| abstract_inverted_index.(DM) | 9 |
| abstract_inverted_index.(HG, | 74 |
| abstract_inverted_index.(NG, | 68 |
| abstract_inverted_index.48h. | 78 |
| abstract_inverted_index.Both | 159 |
| abstract_inverted_index.ChIP | 182 |
| abstract_inverted_index.PAD. | 137, 224 |
| abstract_inverted_index.This | 32 |
| abstract_inverted_index.axis | 217 |
| abstract_inverted_index.blot | 101 |
| abstract_inverted_index.from | 235 |
| abstract_inverted_index.gene | 22 |
| abstract_inverted_index.high | 72 |
| abstract_inverted_index.into | 130 |
| abstract_inverted_index.limb | 211 |
| abstract_inverted_index.mice | 107, 205 |
| abstract_inverted_index.play | 26 |
| abstract_inverted_index.role | 28, 36 |
| abstract_inverted_index.show | 240 |
| abstract_inverted_index.that | 185, 241 |
| abstract_inverted_index.tube | 54, 171 |
| abstract_inverted_index.were | 56, 97, 108, 128 |
| abstract_inverted_index.with | 11, 110, 136, 152, 206, 223 |
| abstract_inverted_index.<p | 0 |
| abstract_inverted_index.(cell | 51 |
| abstract_inverted_index.HAECs | 141, 168 |
| abstract_inverted_index.SETD7 | 85, 112, 143, 148, 160, 174, 242 |
| abstract_inverted_index.These | 238 |
| abstract_inverted_index.cells | 62, 233 |
| abstract_inverted_index.could | 25 |
| abstract_inverted_index.human | 59 |
| abstract_inverted_index.note, | 226 |
| abstract_inverted_index.study | 33 |
| abstract_inverted_index.while | 173 |
| abstract_inverted_index.(PAD). | 15 |
| abstract_inverted_index.aortic | 60 |
| abstract_inverted_index.artery | 13, 123 |
| abstract_inverted_index.assays | 50, 183 |
| abstract_inverted_index.failed | 3 |
| abstract_inverted_index.levels | 155 |
| abstract_inverted_index.lysine | 94 |
| abstract_inverted_index.normal | 66 |
| abstract_inverted_index.showed | 184 |
| abstract_inverted_index.target | 247 |
| abstract_inverted_index.(ChIP). | 105 |
| abstract_inverted_index.(HAECs) | 63 |
| abstract_inverted_index.H3K4me1 | 154, 187 |
| abstract_inverted_index.Histone | 16 |
| abstract_inverted_index.PPARγ. | 202 |
| abstract_inverted_index.RNA-seq | 138, 180 |
| abstract_inverted_index.SEMA3G. | 215 |
| abstract_inverted_index.Western | 100 |
| abstract_inverted_index.blunted | 176 |
| abstract_inverted_index.cohorts | 132 |
| abstract_inverted_index.disease | 14 |
| abstract_inverted_index.enables | 188 |
| abstract_inverted_index.exposed | 64 |
| abstract_inverted_index.femoral | 122 |
| abstract_inverted_index.glucose | 67, 73 |
| abstract_inverted_index.histone | 83, 91 |
| abstract_inverted_index.improve | 5 |
| abstract_inverted_index.outcome | 6 |
| abstract_inverted_index.rescued | 164 |
| abstract_inverted_index.treated | 109 |
| abstract_inverted_index.vehicle | 116 |
| abstract_inverted_index.(SEMA3G) | 196 |
| abstract_inverted_index.Diabetic | 106 |
| abstract_inverted_index.diabetic | 8, 204, 249 |
| abstract_inverted_index.findings | 127, 239 |
| abstract_inverted_index.hindlimb | 119, 207 |
| abstract_inverted_index.improved | 210 |
| abstract_inverted_index.ischemia | 120 |
| abstract_inverted_index.patients | 10, 135, 222 |
| abstract_inverted_index.restored | 228 |
| abstract_inverted_index.unveiled | 142 |
| abstract_inverted_index.(H3K4me1) | 96 |
| abstract_inverted_index.(RNA-seq) | 47 |
| abstract_inverted_index.chromatin | 38, 88, 103, 199 |
| abstract_inverted_index.collected | 234 |
| abstract_inverted_index.defective | 157 |
| abstract_inverted_index.depletion | 161 |
| abstract_inverted_index.druggable | 245 |
| abstract_inverted_index.increased | 153 |
| abstract_inverted_index.inhibitor | 113, 194 |
| abstract_inverted_index.ischemia, | 208 |
| abstract_inverted_index.ligation. | 124 |
| abstract_inverted_index.migration | 52, 169 |
| abstract_inverted_index.patients. | 237 |
| abstract_inverted_index.performed | 57 |
| abstract_inverted_index.perfusion | 212 |
| abstract_inverted_index.response. | 31, 179 |
| abstract_inverted_index.signature | 89 |
| abstract_inverted_index.underwent | 118 |
| abstract_inverted_index.HG-treated | 140 |
| abstract_inverted_index.angiogenic | 30, 49, 178, 229 |
| abstract_inverted_index.associated | 151 |
| abstract_inverted_index.epigenetic | 246 |
| abstract_inverted_index.expression | 23, 80 |
| abstract_inverted_index.formation) | 55 |
| abstract_inverted_index.formation, | 172 |
| abstract_inverted_index.impairment | 166 |
| abstract_inverted_index.increasing | 198 |
| abstract_inverted_index.modulating | 41 |
| abstract_inverted_index.modulators | 20 |
| abstract_inverted_index.peripheral | 12 |
| abstract_inverted_index.properties | 230 |
| abstract_inverted_index.sequencing | 46 |
| abstract_inverted_index.strategies | 2 |
| abstract_inverted_index.translated | 129 |
| abstract_inverted_index.endothelial | 61, 232 |
| abstract_inverted_index.remodelling | 39 |
| abstract_inverted_index.suppressing | 214 |
| abstract_inverted_index.top-ranking | 146 |
| abstract_inverted_index.transcript. | 147 |
| abstract_inverted_index.upregulated | 219 |
| abstract_inverted_index.SETD7/SEMA3G | 216 |
| abstract_inverted_index.angiogenesis | 42, 193 |
| abstract_inverted_index.experimental | 126 |
| abstract_inverted_index.investigated | 98 |
| abstract_inverted_index.investigates | 34 |
| abstract_inverted_index.upregulation | 149 |
| abstract_inverted_index.SETD7-induced | 186 |
| abstract_inverted_index.accessibility | 200 |
| abstract_inverted_index.angiogenesis. | 158 |
| abstract_inverted_index.modifications | 17 |
| abstract_inverted_index.semaphorin-3G | 195 |
| abstract_inverted_index.transcription | 190 |
| abstract_inverted_index.PAD.</p> | 250 |
| abstract_inverted_index.overexpression | 175 |
| abstract_inverted_index.methyltransferase | 84 |
| abstract_inverted_index.immunoprecipitation | 104 |
| abstract_inverted_index.hyperglycemia-induced | 165 |
| abstract_inverted_index.<i>(R)</i>PFI-2 | 163 |
| abstract_inverted_index.<i>(R)</i>-PFI-2 | 114 |
| abstract_inverted_index.(<i>R</i>)-PFI-2 | 209, 227 |
| abstract_inverted_index.dir="ltr">Revascularization | 1 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 18 |
| citation_normalized_percentile.value | 0.07865036 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |